Predicting Autoimmunity Following Treatment of Multiple Sclerosis with Alemtuzumab

被引：1
|
作者：
Jones, Joanne [1 ]
Compston, Alastair [1 ]
Coles, Alasdair [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
来源：
CLINICAL IMMUNOLOGY | 2010年 / 135卷
关键词：
D O I：
10.1016/j.clim.2010.03.310
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] Predicting autoimmunity following treatment of multiple sclerosis with alemtuzumab
    Jones, J. L.
    Compston, D. A. S.
    Coles, A. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S459 - S459
  • [2] Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis
    Azzopardi, Laura
    Thompson, Sara A. J.
    Harding, Katherine E.
    Cossburn, Mark
    Robertson, Neil
    Compston, Alastair
    Coles, Alasdair J.
    Jones, Joanne L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (07): : 795 - 798
  • [3] Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
    Kazakou, Paraskevi
    Tzanetakos, Dimitrios
    Vakrakou, Aigli G.
    Tzartos, John S.
    Evangelopoulos, Maria-Eleptheria
    Anagnostouli, Maria
    Stathopoulos, Panos
    Kassi, Georgia N.
    Stefanis, Leonidas
    Kilidireas, Constantinos
    Zapanti, Evangelia
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2885 - 2894
  • [4] Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
    Paraskevi Kazakou
    Dimitrios Tzanetakos
    Aigli G. Vakrakou
    John S. Tzartos
    Μaria-Eleptheria Evangelopoulos
    Maria Anagnostouli
    Panos Stathopoulos
    Georgia N. Kassi
    Leonidas Stefanis
    Constantinos Kilidireas
    Evangelia Zapanti
    Clinical and Experimental Medicine, 2023, 23 : 2885 - 2894
  • [5] Neuroprotective autoimmunity after alemtuzumab treatment of multiple sclerosis
    Suzanne, Mosely
    Joanne, Jones
    Jane, Anderson
    Chia-Ling, Phuah
    Daniel, Webber
    Alastair, Compston
    Alasdair, Coles
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 93 - 94
  • [6] GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis
    Maniscalco, Giorgia Teresa
    Mariotto, Sara
    Hoeftberger, Romana
    Capra, Ruggero
    Servillo, Giovanna
    Manzo, Valentino
    Napolitano, Massimo
    Candelaresi, Paolo
    Gerevini, Simonetta
    Ferrari, Sergio
    Bozzetti, Silvia
    Spatola, Marianna
    Florio, Ciro
    NEUROLOGY, 2020, 95 (09) : 399 - 401
  • [7] Sarcoidosis following alemtuzumab treatment for multiple sclerosis
    Willis, Mark D.
    Hope-Gill, Ben
    Flood-Page, Patrick
    Joseph, Fady
    Needham, Ed
    Jones, Joanne
    Coles, Alasdair
    Robertson, Neil P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (13) : 1779 - 1782
  • [8] Melanoma following treatment with alemtuzumab for multiple sclerosis
    Pace, A. A.
    Zajicek, J. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (04) : E70 - E71
  • [9] SARCOIDOSIS FOLLOWING ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS
    Willis, M. D.
    May, K.
    Hope-Gill, B.
    Flood-Page, P.
    Jeffrey, D.
    Joseph, F.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A54 - A55
  • [10] Cladribine versus Alemtuzumab: efficacy and autoimmunity in multiple sclerosis induction treatment
    Schmierer, Klaus
    Herrod, Samuel
    Alvarez-Gonzalez, Cesar
    Baker, David
    NEUROLOGY, 2017, 88
12345